Evofem Biosciences (EVFM) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free EVFM Stock Alerts $0.01 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEvofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTOprnewswire.com - April 18 at 8:36 AMEvofem Biosciences, Inc. (EVFM)finance.yahoo.com - April 17 at 9:33 AMEvofem Biosciences, Inc. (EVFM) stock forecast and price targetfinance.yahoo.com - April 17 at 12:45 AMEVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023msn.com - March 27 at 2:39 PMEvofem Reports $18.2 million of Phexxi Net Product Sales in 2023prnewswire.com - March 27 at 8:36 AMEvofem Biosciences, Inc.: Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Calfinanznachrichten.de - March 20 at 5:23 PMFor Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancyprnewswire.com - March 7 at 7:54 AMEvofem Biosciences Stock (OTC:EVFM) Insider Tradesbenzinga.com - February 23 at 12:59 AMEvofem Biosciences Stock (OTC:EVFM), Short Interest Reportbenzinga.com - February 23 at 12:59 AMEvofem Biosciences Inc (EVFM)investing.com - February 13 at 1:19 PMAditxt, Inc. Restructures Debt Post-Merger with Evofemmarkets.businessinsider.com - February 7 at 12:31 PMEvofem Biosciences Announces Merger Agreement with Aditxtmsn.com - February 1 at 9:22 PMEvofem Biosciences achieves 2023 prelim net product sales of $18.1M to $18.3Mmsn.com - February 1 at 4:21 PMEvofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023finance.yahoo.com - February 1 at 9:19 AMWashington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Gamefinance.yahoo.com - January 8 at 8:35 AMEvofem Biosciences Inc EVFMmorningstar.com - January 3 at 6:40 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLImarkets.businessinsider.com - December 19 at 12:40 PMEVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFMbusinesswire.com - December 18 at 3:39 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, CVLY, EVFM, EARmarkets.businessinsider.com - December 13 at 1:41 PMEvofem just downgraded at Laidlaw, here's whyrealmoney.thestreet.com - December 12 at 8:20 PMShares of Aditxt, Evofem Surge on $100 Million Acquisition Dealmarketwatch.com - December 12 at 10:19 AMAditxt To Acquire Evofem For $100 Mln; ADTX Stock Soarmarkets.businessinsider.com - December 12 at 10:19 AMEVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to Shareholderstmcnet.com - December 12 at 10:19 AMAditxt to acquire women’s health company Evofem Biosciencesmsn.com - December 12 at 10:19 AMAditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globallyfinance.yahoo.com - December 12 at 10:19 AMEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2023finanznachrichten.de - November 14 at 8:29 AMEvofem Biosciences GAAP EPS of $0.10, revenue of $5.11Mmsn.com - November 14 at 8:29 AMEvofem Biosciences Announces Financial Results for the Third Quarter of 2023finance.yahoo.com - November 14 at 8:29 AMEvofem Biosciences expects to see third consecutive quarter of growthmsn.com - October 24 at 10:40 AMEvofem Biosciences Announces Preliminary Results for the Third Quarter of 2023finance.yahoo.com - October 24 at 10:40 AMEvofem to Participate in the Virtual Investor Ask the CEO Conferencefinance.yahoo.com - October 13 at 11:48 AMEvofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expirefinance.yahoo.com - September 27 at 9:50 AMEvofem Biosciences Successfully Amends S.P.A. with Institutional Investorfinance.yahoo.com - September 11 at 9:46 AMEvofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchangefinance.yahoo.com - August 22 at 5:45 PMEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Second Quarter of 2023finanznachrichten.de - August 15 at 5:34 PMEvofem Biosciences Announces Financial Results for the Second Quarter of 2023finance.yahoo.com - August 14 at 5:32 PMEvofem Biosciences (OTC: EVFM)fool.com - July 22 at 3:16 PMEVFM - Evofem Biosciences, Inc.ca.finance.yahoo.com - July 13 at 10:14 PMEvofem to Participate in the Virtual Investor Summer Spotlight Seriesfinance.yahoo.com - July 6 at 12:36 PMEvofem Biosciences GAAP EPS of -$1.85, revenue of $5.81M; reaffirms FY23 EBIDTA outlookmsn.com - June 19 at 9:16 AMEvofem Biosciences Announces Financial Results for the First Quarter of 2023finance.yahoo.com - June 16 at 7:04 PMEvofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023finance.yahoo.com - June 1 at 12:55 PMEvofem Biosciences, Inc.: Evofem Biosciences Announces 1-for-125 Reverse Stock Splitfinanznachrichten.de - May 18 at 9:54 AMEvofem Biosciences Announces 1-for-125 Reverse Stock Splitfinance.yahoo.com - May 17 at 6:57 PMEvofem Biosciences (EVFM) Earnings Dates & Reportsinvesting.com - May 11 at 8:33 AMEvofem Biosciences, Inc.: Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Updatefinanznachrichten.de - April 28 at 9:09 AMEvofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - April 28 at 9:09 AMEvofem Appoints Ivy Zhang as Chief Financial Officer and Secretaryfinance.yahoo.com - April 14 at 10:58 AMShe spent a decade trying to build better women’s health care—now her startup is on the brink of failuremsn.com - April 12 at 6:00 PMEvofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Requiredfinance.yahoo.com - April 12 at 12:45 PM Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. EVFM Media Mentions By Week EVFM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVFM News Sentiment▼0.000.42▲Average Medical News Sentiment EVFM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVFM Articles This Week▼00▲EVFM Articles Average Week Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SciSparc News Neptune Wellness Solutions News Evelo Biosciences News Bellerophon Therapeutics News Biodexa Pharmaceuticals News Aditxt News Sunshine Biopharma News China SXT Pharmaceuticals News Comera Life Sciences News Allarity Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVFM) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
